Systemic lupus erythematosus diagnostic criteria: Difference between revisions
Line 5: | Line 5: | ||
==Diagnostic criteria== | ==Diagnostic criteria== | ||
SLICC criteria for the classification of systemic lupus erythematosus | SLICC criteria for the classification of systemic lupus erythematosus was developed based on the old ACR criteria for the classification of systemic lupus erythematosus to address a more sensitive diagnostic criteria and also to cover weaknesses of the previous ACR criteria. | ||
Based on SLICC criteria, for an SLE diagnosis: | |||
# | * Patient should have either at least 4 of 17 criteria, including at least 1 of the 11 clinical criteria and one of the six immunologic criteria, | ||
'''OR''' | |||
* That the patient has biopsy-proven nephritis compatible with SLE in the presence of antinuclear antibodies (ANA) or anti-double-stranded DNA (dsDNA) antibodies. | |||
#: 7138600 | |||
#: 9324032 | |||
#: 22553077. | |||
{| class="wikitable" | {| class="wikitable" | ||
! | ! | ||
Line 76: | Line 82: | ||
|- | |- | ||
|Leukopenia or lymphopenia | |Leukopenia or lymphopenia | ||
|Leukopenia (<4000/mm3 at least once) (in the absence of other known causes, such as Felty's syndrome, drugs, and portal hypertension), '''OR''' | | | ||
Lymphopenia (<1000/mm3 at least once) (in the absence of other known causes, such as glucocorticoids, drugs, and infection) | * Leukopenia (<4000/mm3 at least once) (in the absence of other known causes, such as Felty's syndrome, drugs, and portal hypertension), '''OR''' | ||
* Lymphopenia (<1000/mm3 at least once) (in the absence of other known causes, such as glucocorticoids, drugs, and infection) | |||
|- | |- | ||
|Thrombocytopenia | |Thrombocytopenia | ||
|Thrombocytopenia (<100,000/mm3) at least once in the absence of other known causes, such as drugs, portal hypertension, and thrombotic thrombocytopenic purpura | | | ||
* Thrombocytopenia (<100,000/mm3) at least once in the absence of other known causes, such as drugs, portal hypertension, and thrombotic thrombocytopenic purpura | |||
|- | |- | ||
|ANA | |ANA | ||
|ANA level above laboratory reference range | | | ||
* ANA level above laboratory reference range | |||
|- | |- | ||
|Anti-dsDNA | |Anti-dsDNA | ||
|Anti-dsDNA antibody level above laboratory reference range (or >twofold the reference range if tested by ELISA) | | | ||
* Anti-dsDNA antibody level above laboratory reference range (or >twofold the reference range if tested by ELISA) | |||
|- | |- | ||
|Anit-SM | |Anit-SM | ||
|Presence of antibody to Sm nuclear antigen | | | ||
* Presence of antibody to Sm nuclear antigen | |||
|- | |- | ||
| rowspan="3" |Immunologic criteria | | rowspan="3" |Immunologic criteria | ||
|Antiphospholipid | |Antiphospholipid | ||
|Antiphospholipid antibody positivity as determined by any of the following: Positive test result for lupus anticoagulant | | | ||
* Antiphospholipid antibody positivity as determined by any of the following: | |||
** Positive test result for lupus anticoagulant | |||
** False-positive test result for rapid plasma reagin | |||
** Medium- or high-titer anticardiolipin antibody level (IgA, IgG, or IgM) | |||
** Positive test result for anti-beta 2-glycoprotein I (IgA, IgG, or IgM) | |||
|- | |- | ||
|Low complement | |Low complement | ||
|Low C3 | | | ||
* Low C3 '''OR''' | |||
* Low C4 '''OR''' | |||
* Low CH50 | |||
|- | |- | ||
|Direct Coombs' test | |Direct Coombs' test | ||
|Direct Coombs' test in the absence of hemolytic anemia | | | ||
* Direct Coombs' test in the absence of hemolytic anemia | |||
|} | |} | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} |
Revision as of 20:53, 5 July 2017
Systemic lupus erythematosus Microchapters |
Differentiating Systemic lupus erythematosus from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Systemic lupus erythematosus diagnostic criteria On the Web |
American Roentgen Ray Society Images of Systemic lupus erythematosus diagnostic criteria |
Systemic lupus erythematosus diagnostic criteria in the news |
Directions to Hospitals Treating Systemic lupus erythematosus |
Risk calculators and risk factors for Systemic lupus erythematosus diagnostic criteria |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mahshid Mir, M.D. [2]
Overview
Diagnostic criteria
SLICC criteria for the classification of systemic lupus erythematosus was developed based on the old ACR criteria for the classification of systemic lupus erythematosus to address a more sensitive diagnostic criteria and also to cover weaknesses of the previous ACR criteria.
Based on SLICC criteria, for an SLE diagnosis:
- Patient should have either at least 4 of 17 criteria, including at least 1 of the 11 clinical criteria and one of the six immunologic criteria,
OR
- That the patient has biopsy-proven nephritis compatible with SLE in the presence of antinuclear antibodies (ANA) or anti-double-stranded DNA (dsDNA) antibodies.
- 7138600
- 9324032
- 22553077.
Criterion | Definition | |
---|---|---|
Clinical criteria | Acute cutaneous lupus |
|
Chronic cutaneous lupus |
| |
Nonscarring alopecia |
| |
Oral or nasal ulcers |
| |
Joint disease |
| |
Serositis |
| |
Renal |
| |
Neurologic |
| |
Hematologic criteria | Hemolytic anemia | |
Leukopenia or lymphopenia |
| |
Thrombocytopenia |
| |
ANA |
| |
Anti-dsDNA |
| |
Anit-SM |
| |
Immunologic criteria | Antiphospholipid |
|
Low complement |
| |
Direct Coombs' test |
|